Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01517919 · ClinicalTrials.gov registry record · NA

Peer-Led Self-Management Support in "Real World" Clinical and Community Settings

A NA study of Diabetes, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
241
Enrollment target
1
Study location

NCT01517919: Completed NA study of Diabetes, sponsored by University of Michigan.

NCT01517919 is a NA study of Diabetes that has completed, run by University of Michigan. The registered enrollment target is 241 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01517919, a NA study of Diabetes, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
241 participants
Enrollment target
1
Study location

Study Summary

This study will systematically evaluate a training program in state-of-the-art behavioral change approaches and facilitation skills for peer leaders and a peer-led diabetes self-management support program designed to be conducted in community and clinic-based settings on an ongoing basis.

Primary Outcome

Clinical, self-care and diabetes-related quality of life improvements including the following measures: A1c, Summary of Diabetes Self-Care Activities Measure, Diabetes Distress Scale (DDS)

Conditions Studied

Interventions

  • BEHAVIORAL Peer-Led Self-Management

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 241 participants
Start Date 2010-01
Est. Completion 2013-12
Phase NA
University of Michigan

1,327 total trials

What the finished NCT01517919 record still lists

NCT01517919 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Peer-Led Self-Management is the first listed.

NCT01517919 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT01517919 about?

NCT01517919 is a clinical study titled "Peer-Led Self-Management Support in "Real World" Clinical and Community Settings". This study will systematically evaluate a training program in state-of-the-art behavioral change approaches and facilitation skills for peer leaders and a peer-led diabetes self-management support program designed to be conducted in community and clinic-based settings on an ongoing basis.

What is the current status of trial NCT01517919?

This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2010-01. Estimated completion is 2013-12.

What conditions does trial NCT01517919 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01517919?

The interventions under investigation include: Peer-Led Self-Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01517919?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01517919 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01517919's enrollment target sits among peer trials

241 132nd of 338 higher than 207 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01189786 · 241 participants · NA

    Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection

  • NCT05050383 · 241 participants · NA

    DISE: Phenotyping Obstruction Patterns

  • NCT05683418 · 241 participants · Phase 1

    A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors

  • NCT07213791 · 241 participants · Phase 1

    A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01517919, the US trial registry maintained by the National Library of Medicine. NCT01517919 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.